Your browser doesn't support javascript.
loading
Targeted activation in localized protein environments via deep red photoredox catalysis.
Tay, Nicholas Eng Soon; Ryu, Keun Ah; Weber, John L; Olow, Aleksandra K; Cabanero, David C; Reichman, David R; Oslund, Rob C; Fadeyi, Olugbeminiyi O; Rovis, Tomislav.
Afiliação
  • Tay NES; Department of Chemistry, Columbia University, New York, NY, USA.
  • Ryu KA; Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA.
  • Weber JL; Department of Chemistry, Columbia University, New York, NY, USA.
  • Olow AK; Genetics and Pharmacogenomics, Merck & Co., Inc., San Francisco, CA, USA.
  • Cabanero DC; Department of Chemistry, Columbia University, New York, NY, USA.
  • Reichman DR; Department of Chemistry, Columbia University, New York, NY, USA.
  • Oslund RC; Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA. rob@induprolabs.com.
  • Fadeyi OO; InduPro, Cambridge, MA, USA. rob@induprolabs.com.
  • Rovis T; Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA. niyi@induprolabs.com.
Nat Chem ; 15(1): 101-109, 2023 01.
Article em En | MEDLINE | ID: mdl-36216892
State-of-the-art photoactivation strategies in chemical biology provide spatiotemporal control and visualization of biological processes. However, using high-energy light (λ < 500 nm) for substrate or photocatalyst sensitization can lead to background activation of photoactive small-molecule probes and reduce its efficacy in complex biological environments. Here we describe the development of targeted aryl azide activation via deep red-light (λ = 660 nm) photoredox catalysis and its use in photocatalysed proximity labelling. We demonstrate that aryl azides are converted to triplet nitrenes via a redox-centric mechanism and show that its spatially localized formation requires both red light and a photocatalyst-targeting modality. This technology was applied in different colon cancer cell systems for targeted protein environment labelling of epithelial cell adhesion molecule (EpCAM). We identified a small subset of proteins with previously known and unknown association to EpCAM, including CDH3, a clinically relevant protein that shares high tumour-selective expression with EpCAM.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Luz Limite: Humans Idioma: En Revista: Nat Chem Assunto da revista: QUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Luz Limite: Humans Idioma: En Revista: Nat Chem Assunto da revista: QUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos